305 related articles for article (PubMed ID: 22419799)
1. Plasmid-encoded PER-7 β-lactamase responsible for ceftazidime resistance in Acinetobacter baumannii isolated in the United Arab Emirates.
Opazo A; Sonnevend A; Lopes B; Hamouda A; Ghazawi A; Pal T; Amyes SG
J Antimicrob Chemother; 2012 Jul; 67(7):1619-22. PubMed ID: 22419799
[TBL] [Abstract][Full Text] [Related]
2. Carbapenem-resistant and OXA-23-producing Acinetobacter baumannii isolates in the United Arab Emirates.
Mugnier P; Poirel L; Pitout M; Nordmann P
Clin Microbiol Infect; 2008 Sep; 14(9):879-82. PubMed ID: 18844691
[TBL] [Abstract][Full Text] [Related]
3. Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007.
Pfeifer Y; Wilharm G; Zander E; Wichelhaus TA; Göttig S; Hunfeld KP; Seifert H; Witte W; Higgins PG
J Antimicrob Chemother; 2011 Sep; 66(9):1998-2001. PubMed ID: 21693460
[TBL] [Abstract][Full Text] [Related]
4. Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan.
Lee MH; Chen TL; Lee YT; Huang L; Kuo SC; Yu KW; Hsueh PR; Dou HY; Su IJ; Fung CP
J Microbiol Immunol Infect; 2013 Dec; 46(6):419-24. PubMed ID: 23010539
[TBL] [Abstract][Full Text] [Related]
5. Wide spread of Tn2006 in an AbaR4-type resistance island among carbapenem-resistant Acinetobacter baumannii clinical isolates in Taiwan.
Lee HY; Chang RC; Su LH; Liu SY; Wu SR; Chuang CH; Chen CL; Chiu CH
Int J Antimicrob Agents; 2012 Aug; 40(2):163-7. PubMed ID: 22743015
[TBL] [Abstract][Full Text] [Related]
6. Diversity of carbapenem resistance mechanisms in Acinetobacter baumannii from a Taiwan hospital: spread of plasmid-borne OXA-72 carbapenemase.
Lu PL; Doumith M; Livermore DM; Chen TP; Woodford N
J Antimicrob Chemother; 2009 Apr; 63(4):641-7. PubMed ID: 19182237
[TBL] [Abstract][Full Text] [Related]
7. Genetic diversity and clonal evolution of carbapenem-resistant Acinetobacter baumannii isolates from Portugal and the dissemination of ST118.
Manageiro V; Jones-Dias D; Ferreira E; Louro D; ; Caniça M
Int J Antimicrob Agents; 2012 Nov; 40(5):398-403. PubMed ID: 22890192
[TBL] [Abstract][Full Text] [Related]
8. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore.
Koh TH; Sng LH; Wang GC; Hsu LY; Zhao Y
J Antimicrob Chemother; 2007 Apr; 59(4):627-32. PubMed ID: 17284537
[TBL] [Abstract][Full Text] [Related]
9. Temporal evolution of carbapenem-resistant Acinetobacter baumannii in Curitiba, southern Brazil.
Schimith Bier KE; Luiz SO; Scheffer MC; Gales AC; Paganini MC; Nascimento AJ; Carignano E; Dalla Costa LM
Am J Infect Control; 2010 May; 38(4):308-14. PubMed ID: 20123152
[TBL] [Abstract][Full Text] [Related]
10. OXA beta-lactamase-mediated carbapenem resistance in Acinetobacter baumannii.
Amudhan SM; Sekar U; Arunagiri K; Sekar B
Indian J Med Microbiol; 2011; 29(3):269-74. PubMed ID: 21860108
[TBL] [Abstract][Full Text] [Related]
11. Characterization of bla(OxA-23) gene regions in isolates of Acinetobacter baumannii.
Wang D; Yan D; Hou W; Zeng X; Qi Y; Chen J
J Microbiol Immunol Infect; 2015 Jun; 48(3):284-90. PubMed ID: 24675065
[TBL] [Abstract][Full Text] [Related]
12. Conversion of OXA-66 into OXA-82 in clinical Acinetobacter baumannii isolates and association with altered carbapenem susceptibility.
Zander E; Chmielarczyk A; Heczko P; Seifert H; Higgins PG
J Antimicrob Chemother; 2013 Feb; 68(2):308-11. PubMed ID: 23014718
[TBL] [Abstract][Full Text] [Related]
13. NDM-2 carbapenemase-producing Acinetobacter baumannii in the United Arab Emirates.
Ghazawi A; Sonnevend A; Bonnin RA; Poirel L; Nordmann P; Hashmey R; Rizvi TA; B Hamadeh M; Pál T
Clin Microbiol Infect; 2012 Feb; 18(2):E34-6. PubMed ID: 22192275
[TBL] [Abstract][Full Text] [Related]
14. Characterisation and clonal dissemination of OXA-23-producing Acinetobacter baumannii in Tabriz, northwest Iran.
Peymani A; Higgins PG; Nahaei MR; Farajnia S; Seifert H
Int J Antimicrob Agents; 2012 Jun; 39(6):526-8. PubMed ID: 22521767
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of OXA-51-type class D beta-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres.
Vahaboglu H; Budak F; Kasap M; Gacar G; Torol S; Karadenizli A; Kolayli F; Eroglu C
J Antimicrob Chemother; 2006 Sep; 58(3):537-42. PubMed ID: 16816400
[TBL] [Abstract][Full Text] [Related]
16. Distribution of blaOXA genes among carbapenem-resistant Acinetobacter baumannii nosocomial strains in Poland.
Nowak P; Paluchowska P; Budak A
New Microbiol; 2012 Jul; 35(3):317-25. PubMed ID: 22842601
[TBL] [Abstract][Full Text] [Related]
17. Carbapenem-resistant Acinetobacter baumannii producing OXA-23 in Thailand.
Niumsup PR; Boonkerd N; Tansawai U; Tiloklurs M
Jpn J Infect Dis; 2009 Mar; 62(2):152-4. PubMed ID: 19305059
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain.
Ruiz M; Marti S; Fernandez-Cuenca F; Pascual A; Vila J
Clin Microbiol Infect; 2007 Dec; 13(12):1192-8. PubMed ID: 17850347
[TBL] [Abstract][Full Text] [Related]
19. bla(OXA-51)-type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii.
Merkier AK; Centrón D
Int J Antimicrob Agents; 2006 Aug; 28(2):110-3. PubMed ID: 16844350
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterisation of multiple drug-resistant Acinetobacter baumannii isolates in southern Taiwan.
Ben RJ; Yang MC; Hsueh JC; Shiang JC; Chien ST
Int J Antimicrob Agents; 2011 Nov; 38(5):403-8. PubMed ID: 21871784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
